Tu1828: SAFETY OF JAK INHIBITORS IN PRIMARY SCLEROSING CHOLANGITIS WITH COMORBID INFLAMMATORY BOWEL DISEASE: IMPORTANCE OF CLOSE LIVER MONITORINGZehra Naseem, Katherine Falloon, Sarah Khan et al.|Gastroenterology|2025Cited by 0
Mo1544: IMPACT OF NOVEL ADVANCED THERAPIES ON PRIMARY SCLEROSING CHOLANGITIS IN PATIENTS WITH COMORBID INFLAMMATORY BOWEL DISEASESZehra Naseem, Katherine Falloon, Florian Rieder et al.|Gastroenterology|2025Cited by 0
Mo1550: RISANKIZUMAB DECREASES ALKALINE PHOSPHATASE LEVELS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND COMORBID INFLAMMATORY BOWEL DISEASESSarah Khan, Katherine Falloon, Florian Rieder et al.|Gastroenterology|2025Cited by 0